Geode Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-360,480
| Closed | -$3.58M | – | 4872 |
|
|
2023
Q1 | $3.58M | Sell |
360,480
-11,849
| -3% | -$117K | ﹤0.01% | 2781 |
|
|
2022
Q4 | $3.71M | Buy |
372,329
+28,878
| +8% | +$215K | ﹤0.01% | 2810 |
|
|
2022
Q3 | $1.89M | Buy |
343,451
+63,995
| +23% | +$355K | ﹤0.01% | 3098 |
|
|
2022
Q2 | $1.02M | Buy |
279,456
+16,463
| +6% | +$77.8K | ﹤0.01% | 3413 |
|
|
2022
Q1 | $1.59M | Sell |
262,993
-4,112
| -2% | -$25.1K | ﹤0.01% | 3374 |
|
|
2021
Q4 | $2.25M | Buy |
267,105
+143,282
| +116% | +$1.25M | ﹤0.01% | 3312 |
|
|
2021
Q3 | $1.12M | Buy |
123,823
+4,086
| +3% | +$35.1K | ﹤0.01% | 3620 |
|
|
2021
Q2 | $969K | Buy |
119,737
+22,131
| +23% | +$152K | ﹤0.01% | 3620 |
|
|
2021
Q1 | $537K | Buy |
97,606
+21,685
| +29% | +$107K | ﹤0.01% | 3777 |
|
|
2020
Q4 | $258K | Buy |
75,921
+13,596
| +22% | +$35.8K | ﹤0.01% | 3807 |
|
|
2020
Q3 | $105K | Hold |
62,325
| – | – | ﹤0.01% | 3892 |
|
|
2020
Q2 | $100K | Hold |
62,325
| – | – | ﹤0.01% | 3858 |
|
|
2020
Q1 | $119K | Hold |
62,325
| – | – | ﹤0.01% | 3713 |
|
|
2019
Q4 | $177K | Hold |
62,325
| – | – | ﹤0.01% | 3836 |
|
|
2019
Q3 | $207K | Hold |
62,325
| – | – | ﹤0.01% | 3751 |
|
|
2019
Q2 | $202K | Hold |
62,325
| – | – | ﹤0.01% | 3790 |
|
|
2019
Q1 | $233K | Hold |
62,325
| – | – | ﹤0.01% | 3693 |
|
|
2018
Q4 | $215K | Hold |
62,325
| – | – | ﹤0.01% | 3653 |
|
|
2018
Q3 | $446K | Buy |
+62,325
| New | +$484K | ﹤0.01% | 3501 |
|
|
2016
Q2 | – | Sell |
-957
| Closed | -$13 | – | 4085 |
|
|
2016
Q1 | $13 | Sell |
957
-1
| -0.1% | -$14 | ﹤0.01% | 4078 |
|
|
2015
Q4 | $16K | Buy |
958
+2
| +0.2% | +$34 | ﹤0.01% | 4104 |
|
|
2015
Q3 | $14K | Buy |
956
+3
| +0.3% | +$57 | ﹤0.01% | 4105 |
|
|
2015
Q2 | $20K | Buy |
953
+1
| +0.1% | +$99 | ﹤0.01% | 3936 |
|
|
2015
Q1 | $181K | Buy |
952
+4
| +0.4% | +$919 | ﹤0.01% | 3618 |
|
|
2014
Q4 | $205K | Buy |
948
+307
| +48% | +$68.5K | ﹤0.01% | 3575 |
|
|
2014
Q3 | $173K | Buy |
641
+43
| +7% | +$11.7K | ﹤0.01% | 3615 |
|
|
2014
Q2 | $182K | Sell |
598
-2
| -0.3% | -$635 | ﹤0.01% | 3545 |
|
|
2014
Q1 | $219K | Buy |
600
+210
| +54% | +$76.2K | ﹤0.01% | 3468 |
|
|
2013
Q4 | $127K | Buy |
390
+4
| +1% | +$1.47K | ﹤0.01% | 3548 |
|
|
2013
Q3 | $166K | Buy |
386
+4
| +1% | +$1.75K | ﹤0.01% | 3369 |
|
|
2013
Q2 | $130K | Buy |
+382
| New | +$144K | ﹤0.01% | 3363 |
|
Geode Capital Management's APEN Position: Q2 2023 in Review
Geode Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 360,480 shares — an estimated $3.58M sold.
Geode Capital Management first reported a position in APEN in Q2 2013 and held it in 31 quarters. The position peaked at $3.71M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Geode Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 360,480 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $3.58M.
- Geode Capital Management first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 31 quarters.
- Geode Capital Management's Apollo Endosurgery, Inc. position peaked at $3.71M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.